1-3 of 3
Katelin C Jackson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant

Clinical Trials & Observations
Scott R. Solomon, Melhem Solh, Lawrence E. Morris, Jr., H. Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Caitlin Guzowski, Katelin C Jackson, Stacey Brown, Asad Bashey
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5215–5224.
https://doi.org/10.1182/bloodadvances.2023010477
Published: 2023
Includes: Supplemental data
Journal Articles

Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide

Clinical Trials & Observations
Scott R. Solomon, Michael T. Aubrey, Xu Zhang, Katelin C. Jackson, Lawrence E. Morris, H. Kent Holland, Melhem M. Solh, Asad Bashey
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5311–5321.
https://doi.org/10.1182/bloodadvances.2020003110
Published: 2020
Includes: Supplemental data
Journal Articles

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

Clinical Trials & Observations
Scott R. Solomon, Melhem Solh, Xu Zhang, Stacey Brown, Katelin C. Jackson, H. Kent Holland, Lawrence E. Morris, Asad Bashey
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3669–3676.
https://doi.org/10.1182/bloodadvances.2020001958
Published: 2020
Includes: Supplemental data